» Articles » PMID: 30546424

Potential Clinical Value and Putative Biological Function of MiR-122-5p in Hepatocellular Carcinoma: A Comprehensive Study Using Microarray and RNA Sequencing Data

Overview
Journal Oncol Lett
Specialty Oncology
Date 2018 Dec 15
PMID 30546424
Citations 14
Authors
Affiliations
Soon will be listed here.
Abstract

In order to determine the diagnostic efficacy of microRNA (miR)-122-5p and to identify the potential molecular signaling pathways underlying the function of miR-122-5p in hepatocellular carcinoma (HCC), the expression profiles of data collected from The Cancer Genome Atlas (TCGA), Gene Expression Omnibus (GEO) and literature databases were analyzed, along with any associations between clinicopathological characteristics and the diagnostic value of miR-122-5p in HCC. The intersection of 12 online prediction databases and differentially expressed genes from TCGA and GEO were utilized in order to select the prospective target genes of miR-122-5p in HCC. Gene Ontology (GO), Kyoto Encyclopedia of Genes and Genomes (KEGG) and protein-protein interaction network (PPI) analyses were subsequently performed based on the selected target genes. The average expression level of miR-122-5p was decreased in HCC patients compared with controls from TCGA database (P<0.001), and the downregulation of miR-122-5p was significantly associated with HCC tissues (P<0.001), tumor vascular invasion (P<0.001), metastasis (P=0.001), sex (P=0.006), virus infection status (P=0.001) and tissue (compared with serum; P<0.001) in cases from the GEO database. The pooled sensitivity and specificity for miR-122-5p to diagnose HCC were 0.60 [95% confidence interval (CI), 0.48-0.71] and 0.81 (95% CI, 0.70-0.89), respectively. The area under the curve (AUC) value was 0.76 (95% CI, 0.72-0.80), while in Meta-DiSc 1.4, the AUC was 0.76 (Q*=0.70). The pooled sensitivity and specificity were 0.60 (95% CI, 0.57-0.62) and 0.79 (95% CI, 0.76-0.81), respectively. A total of 198 overlapping genes were selected as the potential target genes of miR-122-5p, and 7 genes were defined as the hub genes from the PPI network. Cell division cycle 6 (CDC6), minichromosome maintenance complex component 4 (MCM4) and MCM8, which serve pivotal functions in the occurrence and development of HCC, were the most significant hub genes. The regulation of cell proliferation for cellular adhesion and the biosynthesis of amino acids was highlighted in the GO and KEGG pathway analyses. The downregulation of miR-122-5p in HCC demonstrated diagnostic value, worthy of further attention. Therefore, miR-122-5p may function as a tumor suppressor by modulating genome replication.

Citing Articles

Role of Circulating microRNAs in Liver Disease and HCC: Focus on miR-122.

Colaianni F, Zelli V, Compagnoni C, Miscione M, Rossi M, Vecchiotti D Genes (Basel). 2024; 15(10).

PMID: 39457437 PMC: 11507253. DOI: 10.3390/genes15101313.


Mechanisms of Tolerance Induction in Liver Transplantation: Lessons Learned from Fetomaternal Tolerance, Autoimmunity and Tumor Immunity.

Nakano T, Goto S, Chen C Int J Mol Sci. 2024; 25(17).

PMID: 39273280 PMC: 11395488. DOI: 10.3390/ijms25179331.


MiR-122-5p regulates erastin-induced ferroptosis via CS in nasopharyngeal carcinoma.

Guo L, Wang Z, Fu Y, Wu S, Zhu Y, Yuan J Sci Rep. 2024; 14(1):10019.

PMID: 38693171 PMC: 11063070. DOI: 10.1038/s41598-024-59080-w.


Multi-omics pan-cancer analyses identify MCM4 as a promising prognostic and diagnostic biomarker.

Li Y, Gao W, Yang Z, Hu Z, Li J Sci Rep. 2024; 14(1):6517.

PMID: 38499612 PMC: 10948783. DOI: 10.1038/s41598-024-57299-1.


miRNA and lncRNA as potential tissue biomarkers in hepatocellular carcinoma.

Mallela V, Rajtmajerova M, Trailin A, Liska V, Hemminki K, Ambrozkiewicz F Noncoding RNA Res. 2023; 9(1):24-32.

PMID: 38075204 PMC: 10700120. DOI: 10.1016/j.ncrna.2023.10.010.


References
1.
Oliveri R, Wetterslev J, Gluud C . Transarterial (chemo)embolisation for unresectable hepatocellular carcinoma. Cochrane Database Syst Rev. 2011; (3):CD004787. DOI: 10.1002/14651858.CD004787.pub2. View

2.
Lee M, Lee H . DMirNet: Inferring direct microRNA-mRNA association networks. BMC Syst Biol. 2017; 10(Suppl 5):125. PMC: 5249041. DOI: 10.1186/s12918-016-0373-1. View

3.
Marrero J, Feng Z, Wang Y, Nguyen M, Befeler A, Roberts L . Alpha-fetoprotein, des-gamma carboxyprothrombin, and lectin-bound alpha-fetoprotein in early hepatocellular carcinoma. Gastroenterology. 2009; 137(1):110-8. PMC: 2704256. DOI: 10.1053/j.gastro.2009.04.005. View

4.
Kosakowska-Cholody T, Cholody W, Hariprakasha H, Monks A, Kar S, Wang M . Growth inhibition of hepatocellular carcinoma cells in vitro and in vivo by the 8-methoxy analog of WMC79. Cancer Chemother Pharmacol. 2008; 63(5):769-78. DOI: 10.1007/s00280-008-0801-z. View

5.
Szklarczyk D, Morris J, Cook H, Kuhn M, Wyder S, Simonovic M . The STRING database in 2017: quality-controlled protein-protein association networks, made broadly accessible. Nucleic Acids Res. 2016; 45(D1):D362-D368. PMC: 5210637. DOI: 10.1093/nar/gkw937. View